1. Adelaide Research & Scholarship
  2. Schools and Disciplines
  3. School of Medicine
  4. Psychiatry
  5. Psychiatry publications
Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/135667
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMinelli, A.-
dc.contributor.authorBarlati, S.-
dc.contributor.authorBaune, B.T.-
dc.date.issued2022-
dc.identifier.citationEuropean Neuropsychopharmacology, 2022; 59:68-81-
dc.identifier.issn0924-977X-
dc.identifier.issn1873-7862-
dc.identifier.urihttps://hdl.handle.net/2440/135667-
dc.description.abstractAbstract not available-
dc.description.statementofresponsibilityAlessandra Minelli, Stefano Barlatic, Bernhard T Baunee, European College of Neuropsychopharmacology, ECNP, Pharmacogenomics, Transcriptomics Network-
dc.language.isoen-
dc.publisherElsevier BV-
dc.rights© 2022 Elsevier B.V. and ECNP. All rights reserved.-
dc.source.urihttp://dx.doi.org/10.1016/j.euroneuro.2022.04.007-
dc.subjectMajor depressive disorder; Randomized controlled trial; Remission-
dc.subject.meshHumans-
dc.subject.meshAntidepressive Agents-
dc.subject.meshTreatment Outcome-
dc.subject.meshDepressive Disorder, Major-
dc.subject.meshPharmacogenetics-
dc.subject.meshPharmacogenomic Testing-
dc.titleEvaluating study designs and treatment outcomes of antidepressant pharmacogenetic clinical trials - Challenges and future perspectives. A critical review-
dc.typeJournal article-
dc.identifier.doi10.1016/j.euroneuro.2022.04.007-
dc.relation.grantNHMRC-
pubs.publication-statusPublished-
dc.identifier.orcidBaune, B.T. [0000-0001-6548-426X]-
Appears in Collections:Psychiatry publications

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.